Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias.

Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E.

Neurosci Lett. 2012 Nov 30;531(1):1-4. doi: 10.1016/j.neulet.2012.09.062. Epub 2012 Oct 13. Erratum in: Neurosci Lett. 2014 Sep 19;580:178.

PMID:
23069674
2.

Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementias.

Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E.

Am J Geriatr Psychiatry. 2014 Jun;22(6):580-6. doi: 10.1016/j.jagp.2012.11.001. Epub 2013 Apr 9.

PMID:
23582751
3.

Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies.

Gatt AP, Jones EL, Francis PT, Ballard C, Bateman JM.

Neurosci Lett. 2013 Dec 17;557 Pt B:177-80. doi: 10.1016/j.neulet.2013.10.045. Epub 2013 Oct 30. Erratum in: Neurosci Lett. 2014 Mar 20;563:44.

PMID:
24184878
4.

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.

Białecka M, Kurzawski M, Roszmann A, Robowski P, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Jarosz M, Gołąb-Janowska M, Koziorowska-Gawron E, Droździk M, Sławek J.

Pharmacogenet Genomics. 2012 Oct;22(10):716-24. doi: 10.1097/FPC.0b013e32835693f7.

PMID:
22890010
5.

COMT Val158Met-stress interaction in psychosis: role of background psychosis risk.

Collip D, van Winkel R, Peerbooms O, Lataster T, Thewissen V, Lardinois M, Drukker M, Rutten BP, Van Os J, Myin-Germeys I.

CNS Neurosci Ther. 2011 Dec;17(6):612-9. doi: 10.1111/j.1755-5949.2010.00213.x. Epub 2010 Nov 14.

PMID:
21073668
6.

Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease.

Varanese S, Perfetti B, Monaco D, Thomas A, Bonanni L, Tiraboschi P, Onofrj M.

J Neurol. 2010 Jun;257(6):1004-11. doi: 10.1007/s00415-010-5453-3. Epub 2010 Jan 22.

PMID:
20094726
7.

[Neuropsychiatric features in Dementia with Lewy bodies and Alzheimer's disease].

Hirono N, Mori E, Imamura T, Shimomura T, Hashimoto M.

No To Shinkei. 1998 Jan;50(1):45-9. Japanese.

PMID:
9493198
8.

A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia.

Aarsland D, Ballard C, Larsen JP, McKeith I.

Int J Geriatr Psychiatry. 2001 May;16(5):528-36.

PMID:
11376470
9.

Psychotic symptoms complicate the clinical differentiation of Parkinson's disease with major depressive disorder from dementia with Lewy bodies.

Miyashita M, Sasayama D, Sugiyama N, Yasaki T, Washizuka S, Amano N.

Psychogeriatrics. 2010 Jun;10(2):107-11. doi: 10.1111/j.1479-8301.2010.00321.x.

10.

Lack of association between COMT Val158Met polymorphism and late-onset Alzheimer's disease in Han Chinese.

Zhou J, Li XM, Jiang T, Liu Y, Chi S, Yu JT, Tan L.

Neurosci Lett. 2013 Oct 25;554:162-6. doi: 10.1016/j.neulet.2013.09.006. Epub 2013 Sep 11.

PMID:
24035893
11.

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P.

Biol Psychiatry. 2008 Nov 15;64(10):850-5. doi: 10.1016/j.biopsych.2008.02.016. Epub 2008 Apr 8.

PMID:
18395699
12.

Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson's disease with dementia.

Horimoto Y, Matsumoto M, Nakazawa H, Yuasa H, Morishita M, Akatsu H, Ikari H, Yamamoto T, Kosaka K.

J Neurol Sci. 2003 Dec 15;216(1):105-8.

PMID:
14607310
13.

A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.

Thomas AJ, Burn DJ, Rowan EN, Littlewood E, Newby J, Cousins D, Pakrasi S, Richardson J, Sanders J, McKeith IG.

Int J Geriatr Psychiatry. 2005 Oct;20(10):938-44.

PMID:
16163744
14.

Catechol-o-methyltransferase gene polymorphism in dementia with Lewy bodies-related psychosis: evidence for a genetic predisposition.

Borroni B, Di Luca M, Padovani A.

Int Psychogeriatr. 2006 Dec;18(4):755-7. No abstract available.

PMID:
17026782
15.

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.

Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF; SNCA Cognition Study Group, Goldman JG, Dalrymple-Alford JC, Geurtsen GJ, Litvan I, Ross OA, Middleton LT, Parkkinen L, Farrer MJ.

Ann Neurol. 2016 Jun;79(6):991-9. doi: 10.1002/ana.24664. Epub 2016 May 5.

PMID:
27091628
16.

Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.

Camicioli R, Rajput A, Rajput M, Reece C, Payami H, Hao C, Rajput A.

Mov Disord. 2005 Aug;20(8):989-94.

PMID:
15852364
17.

Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia.

Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, Campdelacreu J, Gascon J, Falcon C, Calopa M, Jauma S, Juncadella M, Junque C.

Mov Disord. 2010 Apr 15;25(5):615-22. doi: 10.1002/mds.22873.

PMID:
20175186
18.

Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease.

Aarsland D, Cummings JL, Larsen JP.

Int J Geriatr Psychiatry. 2001 Feb;16(2):184-91.

PMID:
11241724
19.

Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnoses.

Rockwell E, Choure J, Galasko D, Olichney J, Jeste DV.

Int J Geriatr Psychiatry. 2000 Sep;15(9):819-23.

PMID:
10984728
20.

Dementia with lewy bodies: findings from an international multicentre study.

Del Ser T, McKeith I, Anand R, Cicin-Sain A, Ferrara R, Spiegel R.

Int J Geriatr Psychiatry. 2000 Nov;15(11):1034-45.

PMID:
11113984

Supplemental Content

Support Center